GeneThera, Inc.
GTHR · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $124 | $146 | $131 | $282 |
| SG&A Expenses | $124 | $146 | $131 | $282 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $1 | $1 | -$4 |
| Operating Expenses | $125 | $147 | $132 | $278 |
| Operating Income | -$125 | -$147 | -$132 | -$278 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | $3 |
| Pre-Tax Income | -$126 | -$148 | -$133 | -$275 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$126 | -$148 | -$133 | -$275 |
| % Margin | – | – | – | – |
| EPS | -0.004 | -0.004 | -0.004 | -0.01 |
| % Growth | 14% | -10.3% | 60.6% | – |
| EPS Diluted | -0.004 | -0.004 | -0.004 | -0.01 |
| Weighted Avg Shares Out | 34,203 | 34,203 | 34,083 | 34,083 |
| Weighted Avg Shares Out Dil | 34,203 | 34,203 | 34,083 | 34,083 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $1 | $2 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$124 | -$147 | -$131 | -$271 |
| % Margin | – | – | – | – |